Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Bonassi

Showing results (231-240 of 247) with videos related to

Pageof 25
Sort By:
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
Nature Protocols|October 27, 2020
Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and resultsPeter Møller, Amaya Azqueta, Elisa Boutet-Robinet, et al.
Gerontology|December 20, 2022
Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European CohortsRobertina Giacconi, Blanca Laffon, Solange Costa, et al.
Journal of Neurology|May 7, 2025
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II)Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Plos One|April 30, 2013
Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association studyGiuseppe Matullo, Simonetta Guarrera, Marta Betti, et al.
Mutation Research|July 19, 2011
The HUman MicroNucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocolStefano Bonassi, Erdem Coskun, Marcello Ceppi, et al.
Mutation Research|December 31, 2002
Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN projectMichael Fenech, Stefano Bonassi, Julie Turner, et al.
Carcinogenesis|December 27, 2011
Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer ConsortiumAlbert Rosenberger, Heike Bickeböller, Valerie McCormack, et al.
Scientific Reports|August 19, 2021
DNA damage in circulating leukocytes measured with the comet assay may predict the risk of deathStefano Bonassi, Marcello Ceppi, Peter Møller, et al.
Pageof 25

Showing results (231-240 of 247) with videos related to

Sort By:
Pageof 25
Neurology and Therapy|March 7, 2024
Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 StudyPiero Barbanti, Gabriella Egeo, Stefania Proietti, et al.
Neurology and Therapy|June 9, 2026
Real-World Response and Super-Response to Eptinezumab over 48 Weeks in Migraine: The Prospective Multicenter EMBRACE III StudyPiero Barbanti, Cinzia Aurilia, Massimo Filippi, et al.
Nature Protocols|October 27, 2020
Minimum Information for Reporting on the Comet Assay (MIRCA): recommendations for describing comet assay procedures and resultsPeter Møller, Amaya Azqueta, Elisa Boutet-Robinet, et al.
Gerontology|December 20, 2022
Association of Torquetenovirus Viremia with Physical Frailty and Cognitive Impairment in Three Independent European CohortsRobertina Giacconi, Blanca Laffon, Solange Costa, et al.
Journal of Neurology|May 7, 2025
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II)Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Plos One|April 30, 2013
Genetic variants associated with increased risk of malignant pleural mesothelioma: a genome-wide association studyGiuseppe Matullo, Simonetta Guarrera, Marta Betti, et al.
Mutation Research|July 19, 2011
The HUman MicroNucleus project on eXfoLiated buccal cells (HUMN(XL)): the role of life-style, host factors, occupational exposures, health status, and assay protocolStefano Bonassi, Erdem Coskun, Marcello Ceppi, et al.
Mutation Research|December 31, 2002
Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN projectMichael Fenech, Stefano Bonassi, Julie Turner, et al.
Carcinogenesis|December 27, 2011
Asthma and lung cancer risk: a systematic investigation by the International Lung Cancer ConsortiumAlbert Rosenberger, Heike Bickeböller, Valerie McCormack, et al.
Scientific Reports|August 19, 2021
DNA damage in circulating leukocytes measured with the comet assay may predict the risk of deathStefano Bonassi, Marcello Ceppi, Peter Møller, et al.
Pageof 25